Literature DB >> 9817252

Gastrointestinal malignancies in patients with celiac sprue.

V E Pricolo1, A A Mangi, B Aswad, K I Bland.   

Abstract

BACKGROUND: Celiac sprue is a malabsorption disease, which carries an increased risk of gastrointestinal malignancy, often underestimated. The purpose of this study was to examine the management of patients with gastrointestinal neoplasms complicating celiac disease. PATIENTS AND METHODS: The pathology database at our institution was searched from 1986 to present; and the literature from 1966 to 1997 was reviewed to identify reports of celiac sprue complicated by malignancy. A total of 82 cases were available for analysis.
RESULTS: Two thirds of patients had carried the diagnosis of celiac sprue for a mean of approximately 10 years. The remaining one third were diagnosed with celiac disease and gastrointestinal malignancy simultaneously. Jejunal T-cell lymphoma was the most common malignancy. There was also an increased frequency of small intestinal adenocarcinoma and squamous cell carcinoma of the esophagus. Prognosis was generally poor, related to the histologic type and stage of the disease.
CONCLUSIONS: Gastrointestinal malignant neoplasms, especially small bowel lymphomas, can occur in patients with celiac sprue. Patients with known celiac disease who present with exacerbation of symptoms should be promptly investigated for occult gastrointestinal malignancies, and considered for early surgical exploration.

Entities:  

Mesh:

Year:  1998        PMID: 9817252     DOI: 10.1016/s0002-9610(98)00193-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  10 in total

1.  Prevalence and demographic characteristics of celiac disease among blood donors in Ribeirão Preto, State of São Paulo, Brazil.

Authors:  Suzeidi Bernardo Castanheira Melo; Maria Inez Machado Fernandes; Luiz Cesar Peres; Luiz Ernesto Almeida Troncon; Livia Carvalho Galvão
Journal:  Dig Dis Sci       Date:  2006-06-07       Impact factor: 3.199

2.  Celiac disease and immunoglobulin a deficiency: how effective are the serological methods of diagnosis?

Authors:  V Kumar; M Jarzabek-Chorzelska; J Sulej; Krystyna Karnewska; T Farrell; S Jablonska
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

3.  Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma.

Authors:  K E Smedby; M Akerman; H Hildebrand; B Glimelius; A Ekbom; J Askling
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

4.  Immunohistochemical analysis of candidate gene product expression in the duodenal epithelium of children with coeliac sprue.

Authors:  I Barshack; I Goldberg; Y Chowers; B Weiss; A Horowitz; J Kopolovic
Journal:  J Clin Pathol       Date:  2001-09       Impact factor: 3.411

Review 5.  Complications of coeliac disease: are all patients at risk?

Authors:  C J R Goddard; H R Gillett
Journal:  Postgrad Med J       Date:  2006-11       Impact factor: 2.401

6.  Development of clinical celiac disease after pancreatoduodenectomy: a potential complication of major upper abdominal surgery.

Authors:  Aljamir D Chedid; Cleber R P Kruel; Marcio F Chedid; Ronaldo J S Torresini; Geraldo R Geyer
Journal:  Langenbecks Arch Surg       Date:  2004-09-24       Impact factor: 3.445

7.  Duodenal Signet Ring Cell Carcinoma in a Celiac Patient.

Authors:  Franco Pisello; Girolamo Geraci; Francesco Li Volsi; Francesca Stassi; Giuseppe Modica; Carmelo Sciumè
Journal:  Case Rep Gastroenterol       Date:  2009-04-10

8.  Coeliac disease presenting with colonic lymphoma.

Authors:  V Koo; A Armstrong; C Harvey
Journal:  Ulster Med J       Date:  2002-11

9.  An unusual presentation of EATL type 1: Emergency surgery due to life-threatening gastrointestinal bleeding.

Authors:  Erdem Kinaci; Mehmet Emin Gunes; Gulben Erdem Huq
Journal:  Int J Surg Case Rep       Date:  2013-08-24

Review 10.  Glyphosate, pathways to modern diseases II: Celiac sprue and gluten intolerance.

Authors:  Anthony Samsel; Stephanie Seneff
Journal:  Interdiscip Toxicol       Date:  2013-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.